Clinical Trial Update: PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study [Phase 3]

View source ↗

Summary

Phase 3 comparative effectiveness study comparing esketamine (Spravato) to ketamine for depression is currently recruiting to assess equivalence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (Spravato) (esketamine)
• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Depression | Phase 3 | Status: RECRUITING